As of August 28, 2026, Sinovac Biotech Ltd. (SVA) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Sinovac Biotech Ltd. has 71.86M shares outstanding, 29 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for SVA.
Market Data
Market CapN/A
Shares Outstanding71.86M
FloatN/A
Cash$5.97B
Debt$498.18M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 56.4% shares (2026Q1 vs prior)
29 institutional holders · 16.42M shares
#1
Vivo Capital, LLC
11.81M shares
#2
ORBIMED ADVISORS LLC
2.72M shares
#3
RENAISSANCE TECHNOLOGIES LLC
1.31M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest82.2K
Days to Cover1000.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track SVA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SVA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.